Page last updated: 2024-10-30

mesalamine and Respiratory Insufficiency

mesalamine has been researched along with Respiratory Insufficiency in 1 studies

Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.

Respiratory Insufficiency: Failure to adequately provide oxygen to cells of the body and to remove excess carbon dioxide from them. (Stedman, 25th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abraham, A1
Karakurum, A1

Other Studies

1 other study available for mesalamine and Respiratory Insufficiency

ArticleYear
Acute respiratory failure secondary to mesalamine-induced interstitial pneumonitis.
    BMJ case reports, 2013, Aug-20, Volume: 2013

    Topics: Acute Lung Injury; Aged; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Humans; Lung

2013